Jay Hetzel PhD, FTSE, FAICD


Dr Hetzel has a background in life sciences research, product development and commercialisation.  He had a distinguished research career with CSIRO for more than 20 years in animal genetics and genomics. In 1998 he co-founded Genetic Solutions to commercialise genomics technology in livestock. The company was sold to Pfizer Animal Health in 2008. He has since worked on commercialising a range of bio-based products in early-stage ventures, is currently Chairman of ASX-listed Leaf Resources and a Director of Anatara Lifesciences. He is a Fellow of the Australian Academy of Technology and Engineering and a Fellow of the Australian Institute of Company Directors. 



Neil Hatherly BSc (Hons), FAICD, FAusIMM, FAIM


Mr Hatherly has extensive board governance experience in several sectors, including listed companies, government-owned corporations, universities, and not-for-profit organisations.  Neil is currently Chairman, Field Services Group, Brisbane City Council; a member of the council’s Audit Committee; a director of the Mount Isa Water Board and a syndicate Chairman of the CEO Institute.  His previous directorships included: Runge Group, a listed company supplying IT solutions and mining consulting services; Tarong Energy, a major electricity generator in Queensland; The University of Newcastle, where he was a Councillor and Chairman of the Performance and Planning Committee; Committee for Economic Development of Australia (CEDA).  Other significant roles include: Director, Abused Child Trust and President, Indooroopilly Golf Club.  His executive career included senior roles in hard rock and coal mine companies, working in organisations focused on intellectual property and providing consulting services and project management to the resources, energy, agribusiness, and government sectors. His international experience and speciality consulting areas include: strategic and business planning, performance improvement, information technology, and people and organisation development.  



Gregory Brown BSc, MBA


Mr Brown has more than 30 years’ international business experience in healthcare, working for global medical device companies including: Baxter, Roche, ImpediMed, Immunexpress, StraxCorp and Digene Corporation. He has global experience in product development and commercialisation in the fields of diagnostics, medical devices and biotechnology. He has led sales, device management, distribution networks, regulatory/reimbursement programs and international marketing. Most of his experience was in manufacturing roles in  Europe (UK/Germany/Switzerland) and the US (NY/NJ/DC). Current board directorships include: Cintra Consulting Pty Ltd, StraxCorp Pty Ltd (Chairman) and Immunexpress Group. Previous board directorships include: Intersection Medical Inc, ImpediMed Limited, Minomic Pty Ltd, the CRC for Diagnostics, Genetic Technologies Limited and NASDAQ-listed Trinity Biotech. 


Professor Robyn Ward AM, FAHMS


Prof Robyn Ward is Deputy Vice-Chancellor (Research), Vice-President (Research) and Acting Executive Dean of Medicine at The University of Queensland. With more than 20 years’ experience in lab-based, clinical and health services research in cancer, Prof Ward has a significant record of achievement in translational and clinical cancer research, including more than 200 peer-reviewed publications. Prof Ward’s achievements were recognised by a Commonwealth Health Minister's Award (Excellence in Health and Medical Research, 2004) and the NSW Premier’s Award (Outstanding Cancer Research, 2007). In 2013, she was made a Member of the Order of Australia (AM) for significant service to medical research.



Stephen Denaro B.Bus, CA, MAICD


Stephen has extensive experience in mergers and acquisitions, business valuations, accountancy services, and income tax compliance gained from positions as Company Secretary and Chief Financial Officer of various public companies and with major chartered accountancy firms in Australia and the United Kingdom.  He provides company secretarial services for a number of start-up technology and ASX listed and unlisted public companies. 

Stephen has a Bachelor of Business in Accountancy, Graduate Diploma in Applied Corporate Governance and is a member of the Institute of Chartered Accountants in Australia and the Australian Institute of Company Directors.